Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA burning or stinging feeling at the injection site is one of the more commonly reported skin reactions with Mounjaro (tirzepatide). It usually appears in the minutes immediately after injecting and settles quickly — but understanding what drives it, and how to tell a normal reaction from one that warrants attention, makes starting treatment considerably less stressful. Mounjaro is a prescription-only medicine assessed individually by a clinical prescriber; any skin reaction that concerns you should be discussed with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, in most cases. The Mounjaro patient information leaflet (and the NHS medicines page for tirzepatide) lists injection-site reactions including pain, redness, bruising and itching as common side effects. A burning sensation falls within that cluster. Tirzepatide is delivered subcutaneously (into the fatty layer just under the skin), and the slight acidity of the formulation, combined with the pressure of the injected fluid, can stimulate nerve endings in the tissue. That stimulation is what most people describe as burning or stinging.
It tends to peak in the first 30 to 60 seconds after the needle is withdrawn and then fades. For many people it becomes less noticeable as they settle into the weekly routine and find an approach that works for their own skin. A question our prescribers hear regularly is whether the burning means something has gone wrong — in the vast majority of cases it does not.
What you can do right away: let the pen reach room temperature for 15 to 20 minutes before injecting rather than using it straight from the fridge, inject slowly and steadily, and avoid pressing hard on the site immediately afterwards. These are small adjustments, but they consistently make a difference. Full storage and administration instructions are in the Mounjaro SmPC on the electronic Medicines Compendium.
Technique matters more than most people expect. The most frequent causes of a sharper or prolonged burn include: injecting a cold pen directly from refrigeration, pushing the plunger too quickly, using an injection site that is already bruised or recently used, injecting into an area of tight skin rather than a relaxed pinch of tissue, and not rotating sites between doses.
Cold fluid is the biggest culprit. At 2–8°C, tirzepatide feels noticeably harsher going into tissue; a quarter of an hour on the kitchen counter before you inject takes the edge off significantly. Speed also matters, the KwikPen delivers the dose steadily when held in place for the full duration; pulling away too soon or rushing the injection concentrates the fluid delivery and amplifies the stinging.
Site rotation is equally important. The abdomen, thigh and upper arm are all licensed injection sites, and cycling between them gives each area time to recover. Injecting repeatedly into exactly the same spot can cause localised skin changes that make reactions worse over time. For a closer look at how tirzepatide affects the skin more broadly, the Mounjaro and skin changes page covers a wider range of reactions.
One practical detail: the tracking notification from DPD arrives the morning your pen is on its way, delivered in a plain unbranded box, worth noting because a pen that's been in a warm delivery vehicle all day should not be used until it has been refrigerated and then properly tempered before the next injection.
Most burning is brief and local. The signs that push a reaction into a different category include: redness or swelling that keeps spreading beyond the injection site in the hours after injecting; a raised, warm lump that does not settle within a day or two; skin that blisters, weeps or forms a crust; or a general allergic reaction, flushing, hives elsewhere on the body, difficulty breathing, or a drop in blood pressure. Those warrant same-day medical contact.
A broader safety consideration: the MHRA monitors GLP-1 medicines closely, and patients can report any unexpected side effect (skin or otherwise) directly through the Yellow Card scheme. It is one of the most useful safety tools available, and using it for anything unusual helps regulators spot patterns across thousands of patients.
If you are experiencing recurring injection-site discomfort that disrupts your weekly routine, that is a practical reason to raise it with your prescriber rather than simply tolerating it. Adjustments to technique, or a review of whether a different injection site works better for your body, are entirely normal conversations. You can read about related skin responses on the sore skin on Mounjaro page or explore the wider picture of tirzepatide and skin reactions.
For most people, yes. The first few injections tend to produce the strongest reactions, partly because the technique is unfamiliar and partly because the body is adjusting to a new substance. As weekly injections become routine and technique improves, the sensation typically becomes milder and shorter-lived.
There is also a dose dimension worth mentioning. Mounjaro starts at 2.5mg, a dose whose primary job is to ease your system into treatment before any therapeutic titration begins. Some people notice injection-site reactions shift as their dose increases, simply because the volume delivered changes slightly. If burning feels worse after a dose step, applying the cold-pen-to-room-temperature rule again and double-checking your site rotation usually helps.
Dry skin around injection sites occasionally plays a part too, keeping the skin moisturised and avoiding injection through irritated patches reduces friction. If dryness is part of the picture, the Mounjaro and dry skin page covers that specifically. For questions about how Mounjaro works at a metabolic level, how tirzepatide drives fat loss is a useful starting point. And if you are still weighing up your treatment options, the weight-loss treatment page sets out what is available through a regulated UK prescriber. That said, if the burning is persistent enough to be affecting your confidence about continuing, the right conversation is with a prescriber, someone who can review your full picture, not just the symptom in isolation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.